НовостиBenzingaPiper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5 Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5 Benzinga 2026.10.19 16:22 (GMT+0) Открыть на Benzinga Другие новости